Skip Navigation

Phase 1 Study to Evaluate the safety and pharmacokinetics of palbociclib in combination with irinotecan and temozolomide in pediatric patients with recurrent or refractory solid tumors

Brief Summary

Type:
Multiple Sites (Solid Tumors)

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03709680

Study #:
CMH - ADVL1921

Start Date:
May 01, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03709680

View Complete Trial Details & Eligibility at ClinicalTrials.gov